Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19 ARDSRespiratory Tract Infection Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me